Old Web
English
Sign In
Acemap
>
authorDetail
>
O.I. Kilkku
O.I. Kilkku
Orion Corporation
Levodopa
Parkinson's disease
Selegiline
Medicine
Randomized controlled trial
2
Papers
102
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Early selegiline therapy reduces levodopa dose requirement in Parkinson's disease.
2009
Acta Neurologica Scandinavica
Vilho V. Myllylä
E. H. Heinonen
J. A. Vuorinen
O.I. Kilkku
K. A. Sotaniemi
Show All
Source
Cite
Save
Citations (18)
Effect of selegiline on mortality in patients with Parkinson's disease A meta-analysis
1998
Neurology
C. W. Olanow
Vilho V. Myllylä
K. A. Sotaniemi
J.P. Larsen
S Palhagen
H. Przuntek
E. H. Heinonen
O.I. Kilkku
Risto Lammintausta
O. Mäki-Ikola
U.K. Rinne
Show All
Source
Cite
Save
Citations (84)
1